Modeled urea distribution volume and mortality in the HEMO study

Clinical Journal of the American Society of Nephrology

Volumn 6, Issue 5, 2011, Pages 1129-1138

  Daugirdas, John T ^a   Greene, Tom ^b   Depner, Thomas A ^c   Levin, Nathan W ^d   Chertow, Glenn M ^e  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d RENAL RESEARCH INSTITUTE   (United States)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SERUM ALBUMIN; UREA;

ADULT; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISTRIBUTION VOLUME; FEMALE; FOLLOW UP; HEMODIALYSIS; HOSPITALIZATION; HUMAN; KINETICS; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MORTALITY; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; VASCULAR ACCESS;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD PRESSURE; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PREDICTIVE VALUE OF TESTS; QUALITY OF LIFE; RENAL DIALYSIS; RISK ADJUSTMENT; RISK FACTORS; UREA;

EID: 79957866647     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.06340710     Document Type: Article

References (28)

1. Greene T, Beck GJ, Gassman JJ, Gotch FA, Kusek JW, Levey AS, Levin NW, Schulman G, Eknoyan G: Design and statistical issues of the hemodialysis (HEMO) study. Control Clin Trials 21: 502-525, 2000
2. Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R: Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347: 2010-2019, 2002
3. Owen WF Jr., Lew NL, Liu Y, Lowrie EG, Lazarus JM: The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 329: 1001-1006, 1993
4. Held PJ, Port FK, Wolfe RA, Stannard DC, Carroll CE, Daugirdas JT, Bloembergen WE, Greer JW, Hakim RM: The dose of hemodialysis and patient mortality. Kidney Int 50: 550-556, 1996
5. Saran R, Canaud BJ, Depner TA, Keen ML, McCullough KP, Marshall MR, Port FK: Dose of dialysis: Key lessons from major observational studies and clinical trials. Am J Kidney Dis 44[5 Suppl 2]: 47-53, 2004
6. Greene T, Daugirdas J, Depner T, Allon M, Beck G, Chumlea C, Delmez J, Gotch F, Kusek JW, Levin N, Owen W, Schulman G, Star R, Toto R, Eknoyan G: Hemodialysis Study Group. Association of achieved dialysis dose with mortality in the hemodialysis study: An example of "dose-targeting bias." J Am Soc Nephrol 16: 3371-3380, 2005
7. Daugirdas JT, Greene T, Depner TA, Chumlea C, Rocco MJ, Chertow GM; Hemodialysis (HEMO) Study Group: Anthropometrically estimated total body water volumes are larger than modeled urea volume in chronic hemodialysis patients: Effects of age, race, and gender. Kidney Int 64: 1108-1119, 2003
8. Depner TA, Cheer A: Modeling urea kinetics with two vs. three BUN measurements. A critical comparison. ASAIO Trans 35: 499-502, 1989
9. Depner TA, Greene T, Daugirdas JT, Cheung AK, Gotch FA, Leypoldt JK: Dialyzer performance in the HEMO Study: In vivo K0A and true blood flow determined from a model of cross-dialyzer urea extraction. ASAIO J 50: 85-93, 2004
10. Daugirdas JT, Greene T, Depner TA, Leypoldt J, Gotch F, Schulman G, Star R; Hemodialysis Study Group: Factors that affect postdialysis rebound in serum urea concentration, including the rate of dialysis: Results from the HEMO Study. J Am Soc Nephrol 15: 194-203, 2004
11. Watson PE, Watson ID, Batt RD: Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr 33: 27-39, 1980
12. McClellan WM, Anson C, Birkeli K, Tuttle E: Functional sta-tus and quality of life: Predictor of early mortality among patients entering treatment for end-stage renal disease. J Clin Epidemiol 44: 83-89, 1991
13. Greenfield S, Nelson E: Recent developments and future issues in the use of health status assessment measures in clinical settings. Med Care 30: 23-41, 1992
14. Miskulin DC, Athienites NV, Yan G, Martin AA, Ornt DB, Kusek JW, Meyer KB, Levey AS; Hemodialysis (HEMO) Study Group: Comorbidity assessment using the Index of Coexistent Diseases in a multicenter clinical trial. Kidney Int 60: 1498-1510, 2001
15. Beck G, Weiss B, Collins A, Gassman J, Levey A, Ornt D, Radeva M, Yan G; the HEMO Study Group: Comparison of hospitalization identified in a multi-center clinical trial with an external national database. Control Clin Trials 24: 133S, 2003
16. Laird NM, Ware JH: Random-effects models for longitudinal data. Biometrics 38: 963-974, 1982
17. Diggle PJ, Liang K, Zeger SL: Analysis of Longitudinal Data, Oxford, UK, Clarendon Press, 1994
18. Therneau TM, Grambsch PM: Modeling Survival Data: Extending the Cox Model, New York, Springer-Verlag, 2000
19. Wolfe RA, Ashby VB, Daugirdas JT, Agodoa LY, Jones CA, Port FK: Body size, dose of hemodialysis, and mortality. Am J Kidney Dis 35: 80-88, 2000
20. Daugirdas JT, Schneditz D, Leehey DJ: Effect of access recirculation on the modeled urea distribution volume. Am J Kidney Dis 27: 512-518, 1996
21. Inrig JK, Patel UD, Toto RD, Szczech LA: Association of blood pressure increases during hemodialysis with 2-year mortality in incident hemodialysis patients: A secondary analysis of the Dialysis Morbidity and Mortality Wave 2 Study. Am J Kidney Dis 54: 881-890, 2009
22. Inrig JK, Oddone EZ, Hasselblad V, Gillespie B, Patel UD, Reddan D, Toto R, Himmelfarb J, Winchester JF, Stivelman J, Lindsay RM, Szczech LA: Association of intradialytic blood pressure changes with hospitalization and mortality rates in prevalent ESRD patients. Kidney Int 71: 454-461, 2007
23. Saran R, Bragg-Gresham JL, Levin NW, Twardowski ZJ, Wizemann V, Saito A, Kimata N, Gillespie BW, Combe C, Bommer J, Akiba T, Mapes DL, Young EW, Port FK: Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. Kidney Int 69: 1222-1228, 2006
24. Miller JE, Kovesdy CP, Nissenson AR, Mehrotra R, Streja E, Van Wyck D, Greenland S, Kalantar-Zadeh K: Association of hemodialysis treatment time and dose with mortality and the role of race and sex. Am J Kidney Dis 55: 100-112, 2010
25. Brunelli SM, Chertow GM, Ankers ED, Lowrie ED, Thadhani R: Shorter dialysis times are associated with higher mortality among incident hemodialysis patients. Kidney Int 77: 630-662, 2010.
26. Wizemann V, Wabel P, Chamney P, Zaluska W, Moissl U, Rode C, Malecka-Masalska T, Marcelli D: The mortality risk of overhydration in haemodialysis patients. Nephrol Dial Transplant 24: 1574-1579, 2009
27. Daugirdas JT, Schneditz D: Overestimation of hemodialysis dose depends on dialysis efficiency by regional blood flow but not by conventional two pool urea kinetic analysis. ASAIO J 41: M719-M724, 1995
28. Kent JT: Robust properties of likelihood ratio tests. Biometrika 69: 19-27, 1982